Nobivac Feline 1-HCPCh (25x1)

No reviews

$85.95

5576

Usually ships within 1 Business Day

FREE SHIPPING

Add to Wishlist

Product Description

Vaccines MUST be shipped via UPS Next Day Air or UPS 2nd Day Air with a cooler & ice packs. Failure to do so may result in a delay in the shipment of your order. Any vaccine order processed Thursday without next day air shipping or any vaccine order placed Friday-Sunday will be shipped the following Monday. Contact our Customer Support team for more information.

Please allow one (1) business day for processing.

PRICE REDUCED!

Nobivac Feline 1-HCPCh (Formerly Eclipse 4)

Proven to protect against several important feline viruses as well as feline Chlamydophila

Feline Rhinotracheitis, Calici, Panleukopenia, Chlamydia Psittaci Vaccine, Modified Live Virus and Chlamydia.

Nobivac Feline 1-HCPCh vaccine is a modified live virus vaccine for the vaccination of healthy cats 9 weeks of age or older against diseases caused by feline rhinotracheitis, calici and panleukopenia viruses and Chlamydia psittaci.


Precautions: Do not vaccinate pregnant cats.

 

0813 12202016

  • A quality 1-year core vaccine that protects against feline rhinotracheitis, feline panleukopenia (FPV), and feline calicivirus (FCV), plus protects against feline Chlamydophila.
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats1
    • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia2–4
  • Goes beyond core antigen protection to help prevent feline Chlamydophila infection
  • Non-adjuvanted formula
  • Optimal for healthy outdoor cats or cats that board frequently
  • Approved for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses, and Chlamydia psittaci
  • Recommended for use in healthy cats 9 weeks of age or older

Administration and Dosage
For cats 9 weeks of age or older:

  • Subcutaneous or intramuscular injection
  • Initial 1-mL dose administered at 9 weeks of age or older
  • Second 1-mL dose administered 3 to 4 weeks later
  • Annual revaccination with 1 dose is recommended

Product Review

Related Products